57.43
57.43 (0%)
As of Feb 14, 2025
SpringWorks Therapeutics, Inc. [SWTX]
Source:
Company Overview
Springworks Therapeutics, Inc. is a commercial-stage biopharmaceutical company applying a precision medicine approach to developing and commercializing life-changing medicines for underserved patient populations suffering from devastating rare diseases and cancer.
| Country | United States |
| Headquarters | stamford, connecticut |
| Phone Number | 203-883-9490 |
| Industry | manufacturing |
| CEO | Saqib Islam |
| Website | www.springworkstx.com |
Financial Year:
Financial Overview (Dollars in Millions)
| Revenue | $191.6 |
| Operating Profit | $-278.1 |
| Net Income | $-258.1 |
| Net Cash | $-106.3 |
Profit Ratios
| Gross Margin | $179 |
| Operating Margin | -145.2 |
| Profit as % of Revenues | -69.4% |
| Profit as % of Assets | -39.3% |
| Profit as % of Stockholder Equity | -53.7% |
Management Effectiveness
| Return on Equity | -53.7% |
| Return on Assets | -44% |
| Turnover Ratio | 29.2% |
| EBITA | $-278.1 |
Balance Sheet and Cash Flow Measures
| Total Assets | $587.3 |
| Total Liabilities | $106.2 |
| Operating Cash Flow | $-175.6 |
| Investing Cash Flow | $64.5 |
| Financing Cash Flow | $4.8 |
